ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-CD62E Antibody [B-S3] - BSA and Azide free (A341918)

Mouse monoclonal [B-S3] IVD antibody to CD62E for ELISA.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-CD62E Antibody [B-S3] - BSA and Azide free
Description
Mouse monoclonal [B-S3] IVD antibody to CD62E.
Specificity
This product recognizesthe Endothelial Leucocyte Adhesion Molecule-1 (ELAM-1), E-selectin, a 97 kDa protein.
Applications
ELISA
Reactivity
Human
Immunogen
Activated human endothelial cells.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-S3
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
CD62 antigen-like family member E, E-selectin, ELAM-1, ELAM1, Endothelial leukocyte adhesion molecule 1, LECAM2, Leukocyte-endothelial cell adhesion molecule 2, SELE
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-CD62E Antibody [B-S3] - BSA and Azide free (A341918)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CD62E Antibody [B-S3] - BSA and Azide free (A341918)

Proteins predicted to interact with CD62E

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.7% Relevancy Score
99.3% Relevancy Score
98.8% Relevancy Score
98.8% Relevancy Score
98% Relevancy Score
97.9% Relevancy Score
97.9% Relevancy Score